Fortress Biotech
(NASDAQ) FBIO
Fortress Biotech Financials at a Glance
Market Cap
$104.97M
Revenue (TTM)
$66.16M
Net Income (TTM)
$127.77M
EPS (TTM)
$3.18
P/E Ratio
0.99
Dividend
$0.00
Beta (Volatility)
1.14 (Average)
Dividend
$0.00
Beta (Volatility)
1.14 (Average)
Price
$3.16
Volume
34,275
Open
$3.09
Price
$3.16
Volume
34,275
Open
$3.09
Previous Close
$3.16
Daily Range
$3.09 - $3.24
52-Week Range
$1.73 - $4.53
Estimated Earnings Date
Aug 17, 2026
Dividend
$0.00
Beta (Volatility)
1.14 (Average)
Price
$3.16
Volume
34,275
Open
$3.09
Previous Close
$3.16
Daily Range
$3.09 - $3.24
52-Week Range
$1.73 - $4.53
Estimated Earnings Date
Aug 17, 2026
FBIO News
Coronado Biosciences Names New CEO
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Fortress Biotech
Industry
Biotechnology
Sector
Health CareEmployees
78
CEO
Lindsay Allan Rosenwald, MD
Website
www.fortressbiotech.comHeadquarters
Bay Harbor Islands, FL 33154, US
FBIO Financials
Key Financial Metrics (TTM)
Gross Margin
64.51%
Operating Margin
-84.36%
Net Income Margin
193.12%
Return on Equity
163.88%
Return on Capital
-56.55%
Return on Assets
35.80%
Earnings Yield
1.01%
Dividend Yield
0.00%
Payout Ratio
0.39%
Stock Overview
Market Cap
$104.97M
Shares Outstanding
33.22M
Volume
34.27K
Avg. Volume
442.91K
Financials (TTM)
Gross Profit
$42.68M
Operating Income
-$55.81M
EBITDA
$148.02M
Operating Cash Flow
$157.64M
Capital Expenditure
$0.00
Free Cash Flow
$157.64M
Cash & ST Invst.
$255.84M
Total Debt
$53.63M
Fortress Biotech Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$16.04M
+22.1%
Gross Profit
$8.69M
+4.1%
Gross Margin
54.21%
N/A
Market Cap
$104.97M
N/A
Market Cap/Employee
$1.04M
N/A
Employees
101
N/A
Net Income
$110.37M
+1142.8%
EBITDA
$147.36M
+802.1%
Quarterly Fundamentals
Total Cash
$255.84M
+180.1%
Total Debt
$53.63M
-27.8%
Accounts Receivable
$25.51M
+39.1%
Inventory
$9.29M
-25.6%
Long Term Debt
$48.91M
-30.3%
Short Term Debt
$4.72M
+17.0%
Return on Assets
35.80%
N/A
Return on Invested Capital
-22.02%
N/A
Free Cash Flow
$203.85M
+1142.0%
Operating Cash Flow
$203.85M
+1142.0%